BLC
ABBV icon

Brown, Lisle/Cummings’s AbbVie ABBV Stock Holding History

Brown, Lisle/Cummings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3M Buy
28,996
+139
+0.5% +$29.9K 1.64% 12
2026
Q1 		$6.28M Buy
28,857
+278
+1% +$61.7K 1.57% 11
2025
Q4 		$6.53M Buy
28,579
+534
+2% +$122K 1.61% 11
2025
Q3 		$6.49M Hold
28,045
– – 1.67% 11
2025
Q2 		$5.21M Sell
28,045
-174
-0.6% -$32.3K 1.39% 16
2025
Q1 		$5.91M Buy
28,219
+181
+0.6% +$35.2K 1.71% 10
2024
Q4 		$4.98M Sell
28,038
-53
-0.2% -$9.74K 1.49% 12
2024
Q3 		$5.55M Buy
28,091
+1,450
+5% +$271K 1.69% 11
2024
Q2 		$4.57M Buy
26,641
+1,124
+4% +$186K 1.49% 13
2024
Q1 		$4.65M Hold
25,517
– – 1.58% 12
2023
Q4 		$3.95M Buy
25,517
+4,025
+19% +$587K 1.47% 12
2023
Q3 		$3.2M Buy
21,492
+425
+2% +$62.4K 1.45% 17
2023
Q2 		$2.84M Buy
21,067
+1,125
+6% +$165K 1.27% 20
2023
Q1 		$3.18M Sell
19,942
-26
-0.1% -$3.98K 1.61% 12
2022
Q4 		$3.23M Sell
19,968
-953
-5% -$146K 1.73% 10
2022
Q3 		$2.81M Hold
20,921
– – 1.64% 13
2022
Q2 		$3.2M Sell
20,921
-7
-0% -$1.07K 1.77% 13
2022
Q1 		$3.39M Buy
20,928
+65
+0.3% +$9.44K 1.63% 13
2021
Q4 		$2.82M Buy
+20,863
New +$2.46M 1.41% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brown, Lisle/Cummings's ABBV Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its AbbVie (ABBV) stake by 0.48% in Q2 2026, buying an estimated $29.9K and bringing the position to 28,996 shares worth $7.3M. The position accounts for 1.64% of the portfolio, ranked #12.

Brown, Lisle/Cummings first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brown, Lisle/Cummings held 28,996 shares of AbbVie worth $7.3M as of Q2 2026.
  • Brown, Lisle/Cummings bought 139 AbbVie shares in Q2 2026, an estimated $29.9K.
  • AbbVie made up 1.64% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #12 holding.
  • Brown, Lisle/Cummings first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.